Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 6
2004 9
2005 5
2006 6
2007 7
2008 7
2009 21
2010 42
2011 42
2012 38
2013 30
2014 13
2015 14
2016 29
2017 11
2018 17
2019 15
2020 8
2021 27
2022 26
2023 37
2024 33
2025 26

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

399 results

Results by year

Filters applied: . Clear all
Page 1
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy.
Mountzios G, Sun L, Cho BC, Demirci U, Baka S, Gümüş M, Lugini A, Zhu B, Yu Y, Korantzis I, Han JY, Ciuleanu TE, Ahn MJ, Rocha P, Mazières J, Lau SCM, Schuler M, Blackhall F, Yoshida T, Owonikoko TK, Paz-Ares L, Jiang T, Hamidi A, Gauto D, Recondo G, Rudin CM; DeLLphi-304 Investigators. Mountzios G, et al. Among authors: gumus m. N Engl J Med. 2025 Jun 2. doi: 10.1056/NEJMoa2502099. Online ahead of print. N Engl J Med. 2025. PMID: 40454646
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer.
Shitara K, Van Cutsem E, Gümüş M, Lonardi S, de la Fouchardière C, Coutzac C, Dekervel J, Hochhauser D, Shen L, Mansoor W, Liu B, Fornaro L, Ryu MH, Lee J, Faustino C, Metges JP, Tabernero J, Franke F, Janjigian YY, Souza F, Jukofsky L, Zhao Y, Kamio T, Zaanan A, Pietrantonio F; DESTINY-Gastric04 Trial Investigators. Shitara K, et al. Among authors: gumus m. N Engl J Med. 2025 May 31. doi: 10.1056/NEJMoa2503119. Online ahead of print. N Engl J Med. 2025. PMID: 40454632
Temporal muscle thickness as a feasible sarcopenia marker and outcome predictor after aneurysmal subarachnoid hemorrhage.
Mohajerani E, Gümüs M, Dinger TF, Rieß C, Rauschenbach L, Rodemerk J, Ziegenfuß CD, Darkwah Oppong M, Ahmadipour Y, Li Y, Dammann P, Sure U, Jabbarli R. Mohajerani E, et al. Among authors: gumus m. Acta Neurochir (Wien). 2025 May 29;167(1):157. doi: 10.1007/s00701-025-06562-z. Acta Neurochir (Wien). 2025. PMID: 40439824 Free PMC article.
Cemiplimab monotherapy as first-line treatment of patients with brain metastases from advanced non-small cell lung cancer with programmed cell death-ligand 1 ≥50.
Kilickap S, Özgüroğlu M, Sezer A, Gümüş M, Bondarenko I, Gogishvili M, Turk HM, Cicin I, Bentsion D, Gladkov O, Sriuranpong V, Quek RGW, McIntyre DAG, He X, McGinniss J, Seebach F, Gullo G, Rietschel P, Pouliot JF. Kilickap S, et al. Among authors: gumus m. Cancer. 2025 May 15;131(10):e35864. doi: 10.1002/cncr.35864. Cancer. 2025. PMID: 40323717 Free PMC article. Clinical Trial.
399 results